[1]
Woon, D.T., Chandrasekar, T., Aaron, L., Basappa, N.S., Chi, K.N., Conter, H.J., Gotto, G., Hotte, S.J., Malone, S., Saad, F., Shayegan, B., Park-Wyllie, L. and Hamilton, R.J. 2018. Disparity in public funding of therapies for metastatic castrate-resistant prostate cancer across Canadian provinces. Canadian Urological Association Journal. 12, 10 (Jul. 2018). DOI:https://doi.org/10.5489/cuaj.5378.